戻る
Adaptimmune Therapeutics PLC (ADAP)価格
ADAP 株価推移チャート
ADAP 株価予測
Adaptimmune Therapeutics PLC
$0.04
-3%
$0
終値： Feb 06, 16:00:00 GMT-5
$0.04
0%
$0
プレマーケット： Feb 09, 05:18:57 GMT-5
主要データ
前終値
$0.05
始値
$0.0425
当日レンジ
$0.0425 - $0.0599
52週レンジ
$0.0202 - $0.65
取引高
1.6M
平均取引高
64.4M
1株当たり利益(TTM)
-0.11
配当利回り
--
時価総額
$12.8M
ADAPとは何ですか？
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. The company is headquartered in Abingdon, Oxfordshire and currently employs 506 full-time employees. The company went IPO on 2015-05-06. PRAME is highly expressed across a range of solid tumors, including ovarian, endometrial, lung and breast cancers. The CD70 program targets the CD70 antigen, which is expressed across a range of hematological malignancies (acute myeloid leukemia and lymphoma) and solid tumors (renal cell carcinoma). The company is using TRuC technology to develop a T-cell therapy (ADP-520) against CD70, with membrane bound IL-15 to enhance persistence. ADP-520 is in pre-clinical testing. TRuC technology combines the targeting of CAR-T cells with T-cell TCR signaling.